rs721048
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001142616.3(EHBP1):c.1185+30064G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.133 in 152,112 control chromosomes in the GnomAD database, including 1,698 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Genomes: 𝑓 0.13 ( 1698 hom., cov: 31)
Consequence
EHBP1
NM_001142616.3 intron
NM_001142616.3 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.575
Publications
147 publications found
Genes affected
EHBP1 (HGNC:29144): (EH domain binding protein 1) This gene encodes an Eps15 homology domain binding protein. The encoded protein may play a role in endocytic trafficking. A single nucleotide polymorphism in this gene is associated with an aggressive form of prostate cancer. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Feb 2010]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.18 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| EHBP1 | ENST00000431489.6 | c.1185+30064G>A | intron_variant | Intron 10 of 22 | 1 | NM_001142616.3 | ENSP00000403783.1 | |||
| EHBP1 | ENST00000263991.9 | c.1290+30064G>A | intron_variant | Intron 11 of 24 | 1 | ENSP00000263991.5 | ||||
| EHBP1 | ENST00000405289.5 | c.1185+30064G>A | intron_variant | Intron 9 of 22 | 1 | ENSP00000385524.1 | ||||
| EHBP1 | ENST00000405015.7 | c.1185+30064G>A | intron_variant | Intron 10 of 22 | 2 | ENSP00000384143.3 |
Frequencies
GnomAD3 genomes AF: 0.133 AC: 20219AN: 151994Hom.: 1697 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
20219
AN:
151994
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.133 AC: 20208AN: 152112Hom.: 1698 Cov.: 31 AF XY: 0.133 AC XY: 9868AN XY: 74366 show subpopulations
GnomAD4 genome
AF:
AC:
20208
AN:
152112
Hom.:
Cov.:
31
AF XY:
AC XY:
9868
AN XY:
74366
show subpopulations
African (AFR)
AF:
AC:
1517
AN:
41510
American (AMR)
AF:
AC:
2821
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
AC:
552
AN:
3468
East Asian (EAS)
AF:
AC:
246
AN:
5164
South Asian (SAS)
AF:
AC:
483
AN:
4812
European-Finnish (FIN)
AF:
AC:
1646
AN:
10590
Middle Eastern (MID)
AF:
AC:
27
AN:
294
European-Non Finnish (NFE)
AF:
AC:
12415
AN:
67966
Other (OTH)
AF:
AC:
337
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
871
1741
2612
3482
4353
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
212
424
636
848
1060
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
285
AN:
3478
ClinVar
Significance: Uncertain significance
Submissions summary: Pathogenic:1Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Prostate cancer, hereditary, 12 Pathogenic:1Uncertain:1
Dec 18, 2024
Genomic Medicine Center of Excellence, King Faisal Specialist Hospital and Research Centre
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Mar 01, 2008
OMIM
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:literature only
- -
EHBP1-related disorder Uncertain:1
Apr 17, 2023
Department of Pathology and Laboratory Medicine, Sinai Health System
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:research
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.